Newsfeeds - Spark Newswire

2 minute read

3 Stocks Insiders Are Buying

Today, 4:08 PM

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

MYOV

3 minute read

The Past Week’s Notable Insider Buys: Cano Health, Cricut, GoodRx, SelectQuote And More

By Nelson Hem

Today, 4:08 PM

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some insiders were making return trips to the buy window last week. Some chief executives were adding to their stakes as well.

CANO

2 minute read

3 Stocks Insiders Are Buying

By Lisa Levin

Today, 4:08 PM

CVGI

3 minute read

The Past Week’s Notable Insider Buys Included AppLovin, Cricut, Biotechs And More

By Nelson Hem

Today, 4:08 PM

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some insiders were making return trips to the buy window last week. Insider buying was also happening in the wake of recent earnings reports.

AMEH

6 minute read

The Daily Biotech Pulse: Moderna’s Vaccine Produces Durable Response Against Variants, FDA Approves Jazz’s Sleep Disorder Drug, Dermata IPO

By Shanthi Rexaline

Today, 4:08 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12)

ABVC

4 minute read

FDA
News

Myovant Highlights Results From Trials Of Enzyvant’s RVT-802 Were Published In ‘The Journal Of Allergy, Clinical Immunology’

By Benzinga Newsdesk

Today, 4:08 PM

Kaplan-Meier estimated survival at one year and two years post treatment with investigational RVT-802 was 77% and 76%, respectively Follow-up time in the Efficacy Analysis Set (EAS) ranged from 0 to 25.5 years; For

MYOV

5 minute read

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer’s Conference, IPOs and More

By Shanthi Rexaline

Today, 4:08 PM

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season.

ABBV

7 minute read

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street

By Shanthi Rexaline

Today, 4:08 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19)

ABIO

1 minute read

Europe OK’s Myovant’s Relugolix Combo Therapy For Uterine Fibroids

By Vandana Singh

Today, 4:08 PM

The European Commission (EC) has approved Myovant Sciences Ltd’s (NYSE:MYOV) Ryeqo (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5…

MYOV

2 minute read

Myovant Sciences Announced European Commission Approval for RYEQO® for the Treatment of Women With Uterine Fibroids

By Charles Gross

Today, 4:08 PM

Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced the European Commission (EC) has approved the marketing authorization application for RYEQO® (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg) for the treatment of moderate to severe symp

MYOV